Correlation Between Scpharmaceuticals and Beam Therapeutics
Can any of the company-specific risk be diversified away by investing in both Scpharmaceuticals and Beam Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Scpharmaceuticals and Beam Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Scpharmaceuticals and Beam Therapeutics, you can compare the effects of market volatilities on Scpharmaceuticals and Beam Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Scpharmaceuticals with a short position of Beam Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Scpharmaceuticals and Beam Therapeutics.
Diversification Opportunities for Scpharmaceuticals and Beam Therapeutics
0.17 | Correlation Coefficient |
Average diversification
The 3 months correlation between Scpharmaceuticals and Beam is 0.17. Overlapping area represents the amount of risk that can be diversified away by holding Scpharmaceuticals and Beam Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Beam Therapeutics and Scpharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Scpharmaceuticals are associated (or correlated) with Beam Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Beam Therapeutics has no effect on the direction of Scpharmaceuticals i.e., Scpharmaceuticals and Beam Therapeutics go up and down completely randomly.
Pair Corralation between Scpharmaceuticals and Beam Therapeutics
Given the investment horizon of 90 days Scpharmaceuticals is expected to under-perform the Beam Therapeutics. In addition to that, Scpharmaceuticals is 1.04 times more volatile than Beam Therapeutics. It trades about 0.0 of its total potential returns per unit of risk. Beam Therapeutics is currently generating about 0.03 per unit of volatility. If you would invest 2,422 in Beam Therapeutics on August 25, 2024 and sell it today you would earn a total of 83.00 from holding Beam Therapeutics or generate 3.43% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Scpharmaceuticals vs. Beam Therapeutics
Performance |
| Timeline |
| Scpharmaceuticals |
| Beam Therapeutics |
Scpharmaceuticals and Beam Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Scpharmaceuticals and Beam Therapeutics
The main advantage of trading using opposite Scpharmaceuticals and Beam Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Scpharmaceuticals position performs unexpectedly, Beam Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Beam Therapeutics will offset losses from the drop in Beam Therapeutics' long position.| Scpharmaceuticals vs. Milestone Pharmaceuticals | Scpharmaceuticals vs. Oncolytics Biotech | Scpharmaceuticals vs. Seres Therapeutics | Scpharmaceuticals vs. DiaMedica Therapeutics |
| Beam Therapeutics vs. Eliem Therapeutics | Beam Therapeutics vs. HCW Biologics | Beam Therapeutics vs. RenovoRx | Beam Therapeutics vs. Scpharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Center module to all portfolio management and optimization tools to improve performance of your portfolios.
Other Complementary Tools
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings |